4.6 Article

Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio

期刊

FRONTIERS IN NEUROLOGY
卷 12, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fneur.2021.763143

关键词

magnetic resonance neurography (MRN); magnetisation transfer ratio (MTR); multiple sclerosis; relapsing-remitting multiple sclerosis (RRMS); peripheral nervous system (PNS)

资金

  1. UK MS Society
  2. UCL-UCLH Biomedical Research Centre
  3. MS Society [77]
  4. Wings for Life [169111]
  5. BRC [BRC704/CAP/CGW]
  6. UCL Global Challenges Research Fund (GCRF)
  7. MRC [MR/S026088/1]
  8. Ataxia UK
  9. non-clinical Postdoctoral Guarantors of Brain fellowship
  10. National Institute for Health Research, UCL Hospitals Biomedical Research Centre - Junior Leader La Caixa Fellowship [LCF/BQ/PI20/11760008]
  11. la Caixa Foundation [100010434]
  12. Fundacion Merck Salud (Spain)
  13. ECTRIMS Post-doctoral Research Fellowship
  14. European Union [634541]
  15. Engineering and Physical Sciences Research Council [EPSRC EP/R006032/1]
  16. AstraZeneca
  17. Medical Research Council [MR/S026088/1] Funding Source: researchfish

向作者/读者索取更多资源

This study aimed to assess peripheral nervous system (PNS) damage in people with relapsing-remitting MS (RRMS) using magnetisation transfer ratio (MTR) imaging at the lumbar plexus and sciatic nerve anatomical locations. The results showed significantly lower MTR values in the sciatic nerve of RRMS patients compared to healthy controls, but no significant changes were identified in the lumbar plexus.
Background: Multiple sclerosis (MS) has traditionally been regarded as a disease confined to the central nervous system (CNS). However, neuropathological, electrophysiological, and imaging studies have demonstrated that the peripheral nervous system (PNS) is also involved, with demyelination and, to a lesser extent, axonal degeneration representing the main pathophysiological mechanisms.Aim: The purpose of this study was to assess PNS damage at the lumbar plexus and sciatic nerve anatomical locations in people with relapsing-remitting MS (RRMS) and healthy controls (HCs) in vivo using magnetisation transfer ratio (MTR), which is a known imaging biomarker sensitive to alterations in myelin content in neural tissue, and not previously explored in the context of PNS damage in MS.Method: Eleven HCs (7 female, mean age 33.6 years, range 24-50) and 15 people with RRMS (12 female, mean age 38.5 years, range 30-56) were recruited for this study and underwent magnetic resonance imaging (MRI) investigations together with clinical assessments using the expanded disability status scale (EDSS). Magnetic resonance neurography (MRN) was first used for visualisation and identification of the lumbar plexus and the sciatic nerve and MTR imaging was subsequently performed using identical scan geometry to MRN, enabling straightforward co-registration of all data to obtain global and regional mean MTR measurements. Linear regression models were used to identify differences in MTR values between HCs and people with RRMS and to identify an association between MTR measures and EDSS.Results: MTR values in the sciatic nerve of people with RRMS were found to be significantly lower compared to HCs, but no significant MTR changes were identified in the lumbar plexus of people with RRMS. The median EDSS in people with RRMS was 2.0 (range, 0-3). No relationship between the MTR measures in the PNS and EDSS were identified at any of the anatomical locations studied in this cohort of people with RRMS.Conclusion: The results from this study demonstrate the presence of PNS damage in people with RRMS and support the notion that these changes, suggestive of demyelination, maybe occurring independently at different anatomical locations within the PNS. Further investigations to confirm these findings and to clarify the pathophysiological basis of these alterations are warranted.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Radiology, Nuclear Medicine & Medical Imaging

Voxel-level analysis of normalized DSC-PWI time-intensity curves: a potential generalizable approach and its proof of concept in discriminating glioblastoma and metastasis

Albert Pons-Escoda, Alonso Garcia-Ruiz, Pablo Naval-Baudin, Francesco Grussu, Juan Jose Sanchez Fernandez, Angels Camins Simo, Noemi Vidal Sarro, Alejandro Fernandez-Coello, Jordi Bruna, Monica Cos, Raquel Perez-Lopez, Carles Majos

Summary: This study proposes a new method for DSC-PWI analysis, which includes all time-points and voxels to generate robust diagnostic models. Satisfactory results were obtained for distinguishing glioblastoma and metastases, with AUCs of 0.71-0.83 and accuracies up to 88%. The method shows promise for presurgical discrimination in heterogeneous diseases.

EUROPEAN RADIOLOGY (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Diffusion MRI signal cumulants and hepatocyte microstructure at fixed diffusion time: Insights from simulations, 9.4T imaging, and histology

Francesco Grussu, Kinga Bernatowicz, Irene Casanova-Salas, Natalia Castro, Paolo Nuciforo, Joaquin Mateo, Ignasi Barba, Raquel Perez-Lopez

Summary: This study investigates the relationship between diffusion-weighted MRI signals and hepatocyte microstructure, and finds that important information about liver cell size and diffusivity can be obtained from minimal diffusion encodings under specific conditions.

MAGNETIC RESONANCE IN MEDICINE (2022)

Article Neuroimaging

Spatial patterns of brain lesions assessed through covariance estimations of lesional voxels in multiple Sclerosis: The SPACE-MS technique

Carmen Tur, Francesco Grussu, Floriana De Angelis, Ferran Prados, Baris Kanber, Alberto Calvi, Arman Eshaghi, Thalis Charalambous, Rosa Cortese, Declan T. Chard, Jeremy Chataway, Alan J. Thompson, Olga Ciccarelli, Claudia A. M. Gandini Wheeler-Kingshott

Summary: Predicting disability in progressive multiple sclerosis (MS) is challenging due to the lack of established quantitative metrics characterizing spatial distribution of white matter (WM) lesions. A novel approach, SPACE-MS, was introduced to quantitatively characterize spatial distributional features of brain MS lesions, showing that lesions in lower parts of the brain and more isotropic spreading of lesions are associated with clinical deterioration in progressive MS. This approach may be applicable to other conditions with brain WM lesions.

NEUROIMAGE-CLINICAL (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of multicenter MRI protocols for visualizing the spinal cord gray matter

Julien Cohen-Adad, Eva Alonso-Ortiz, Stephanie Alley, Maria Marcella Lagana, Francesca Baglio, Signe Johanna Vannesjo, Haleh Karbasforoushan, Maryam Seif, Alan C. Seifert, Junqian Xu, Joo-Won Kim, Rene Labounek, Lubomir Vojtisek, Marek Dostal, Jan Valosek, Rebecca S. Samson, Francesco Grussu, Marco Battiston, Claudia A. M. Gandini Wheeler-Kingshott, Marios C. Yiannakas, Guillaume Gilbert, Torben Schneider, Brian Johnson, Ferran Prados

Summary: This study compared different MRI protocols (1.5 T, 3 T, and 7 T) for visualizing spinal cord gray matter. Qualitative assessments indicated comparable image quality for 3 T and 7 T scans, while 1.5 T scans had moderate to low image quality. The proposed evaluation criteria and metrics can serve as a benchmark for optimizing spinal cord gray matter imaging protocols in the future.

MAGNETIC RESONANCE IN MEDICINE (2022)

Review Clinical Neurology

The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021

Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero, Maria Pia Amato, Tobias Derfuss, Franziska Di Pauli, Ellen Iacobaeus, Marcin Mycko, Hesham Abboud, Anat Achiron, Angelo Bellinvia, Alexey Boyko, Jean-Laurent Casanova, David Clifford, Ruth Dobson, Mauricio F. Farez, Massimo Filippi, Kathryn C. Fitzgerald, Mattia Fonderico, Riadh Gouider, Yael Hacohen, Kerstin Hellwig, Bernhard Hemmer, Ludwig Kappos, Filipa Ladeira, Christine Lebrun-Frenay, Celine Louapre, Melinda Magyari, Matthias Mehling, Celia Oreja-Guevara, Lekha Pandit, Caroline Papeix, Fredrik Piehl, Emilio Portaccio, Isabel Ruiz-Camps, Krzysztof Selmaj, Steve Simpson-Yap, Aksel Siva, Per Soelberg Sorensen, Maria Pia Sormani, Maria Trojano, Adi Vaknin-Dembinsky, Sandra Vukusic, Brian Weinshenker, Heinz Wiendl, Alexander Winkelmann, Maria Isabel Zuluaga Rodas, Mar Tintore, Bruno Stankoff

Summary: In recent years, there have been rapid developments in the treatment of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD), with a wide range of disease-modifying treatments (DMTs) now available. However, most DMTs come with the risk of adverse events, particularly infections. To address this, an international workshop sponsored by the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) was held in April 2021 to review the current knowledge on infection risks associated with DMT use in MS and NMOSD patients, and to discuss strategies for risk mitigation. The workshop also explored specific populations, such as children, pregnant women, individuals with comorbidities, and those living in regions with high infection burden, as well as the impact of the ongoing SARS-CoV-2 pandemic on DMT-associated infectious risks.

MULTIPLE SCLEROSIS JOURNAL (2022)

Article Clinical Neurology

Association of Slowly Expanding Lesions on MRI With Disability in People With Secondary Progressive Multiple Sclerosis

Alberto Calvi, Ferran Prados Carrasco, Carmen Tur, Declan T. Chard, Jonathan Stutters, Floriana De Angelis, Nevin John, Thomas Williams, Anisha Doshi, Rebecca S. Samson, David MacManus, Claudia A. Gandini Wheeler-Kingshott, Olga Ciccarelli, Jeremy Chataway, Frederik Barkhof

Summary: This study found that slowly expanding lesions (SELs) make up a significant proportion of T2 lesions in secondary progressive multiple sclerosis (SPMS). These lesions are associated with neurodegenerative MRI markers and clinical worsening, suggesting that they may contribute to disease progression and be a new target for therapeutic interventions.

NEUROLOGY (2022)

Article Clinical Neurology

Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations

Wallace J. Brownlee, Christian Wolf, Hans-Peter Hartung, Theo Dingermann, Nadia Anshasi, Richard A. C. Clark, Maria Trojano, Krzysztof Selmaj, Bernard M. J. Uitdehaag, Carmen Tur, Jens Wuerfel, Gabriele Dallmann, Julian Witte, Martina Sintzel, Olga Bobrovnikova, Jeffrey A. Cohen

Summary: This study identified best practices for the development and use of follow-on disease-modifying treatments (FO-DMTs) through the appraisal of published evidence. The consensus reached by a multidisciplinary panel supports the safe and effective use of FO-DMTs in treating multiple sclerosis. The findings may contribute to enhanced quality standards for FO-DMTs use in other regions.

MULTIPLE SCLEROSIS JOURNAL (2022)

Article Clinical Neurology

Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging

Rosa Cortese, Ferran Prados Carrasco, Carmen Tur, Alessia Bianchi, Wallace Brownlee, Floriana De Angelis, Isabel de la Paz, Francesco Grussu, Lukas Haider, Anu Jacob, Baris Kanber, Lise Magnollay, Richard S. Nicholas, Anand Trip, Marios Yiannakas, Ahmed T. Toosy, Yael Hacohen, Frederik Barkhof, Olga Ciccarelli

Summary: This study investigated whether imaging characteristics could differentiate between relapsing-remitting multiple sclerosis (RRMS), aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). The results showed that the proportion of lesions with the central vein sign (CVS) was the most accurate measure to differentiate RRMS from AQP4-NMOSD, while white matter lesions were the most accurate measure to discriminate RRMS from MOGAD.

NEUROLOGY (2023)

Article Clinical Neurology

Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis

Alberto Calvi, Margareta A. Clarke, Ferran Prados, Declan Chard, Olga Ciccarelli, Manel Alberich, Deborah Pareto, Marta Rodriguez Barranco, Jaume Sastre-Garriga, Carmen Tur, Alex Rovira, Frederik Barkhof

Summary: This study found that chronic active lesions in magnetic resonance imaging (MRI), known as slowly expanding lesions (SELs) and paramagnetic rim lesions (PRLs), are associated with greater clinical progression in multiple sclerosis (MS) patients. SELs are more numerous than PRLs in MS patients.

MULTIPLE SCLEROSIS JOURNAL (2023)

Editorial Material Clinical Neurology

Treatment De-escalation in AQP4-Ab Neuromyelitis Optica Spectrum Disorder

Yael Hacohen, Carmen Tur

Summary: Aquaporin-4 antibody (AQP4-Ab) neuromyelitis optica spectrum disorder (NMOSD) is a well-recognized autoimmune disease of the CNS that can lead to blindness and paralysis if left untreated. Lifelong treatment is currently recommended.

NEUROLOGY (2023)

Article Clinical Neurology

A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patients

Rene Carvajal, Carmen Tur, Xavier Martinez-Gomez, Luca Bollo, Juliana Esperalba, Marta Rodriguez, Agustin Pappolla, Alvaro Cobo-Calvo, Pere Carbonell, Blanca Borras-Bemejo, Jordi Rio, Joaquin Castillo, Nathane Braga, Neus Mongay-Ochoa, Jose Angel Rodrigo-Pendas, Angela Vidal-Jordana, Georgina Arrambide, Breogan Rodriguez-Acevedo, Ana Zabalza, Luciana Midaglia, Ingrid Galan, Manuel Comabella, Jaume Sastre-Garriga, Xavier Montalban, Mar Tintore, Susana Otero-Romero

Summary: A single-dose attempt of VAR and/or MMR vaccines could effectively protect almost two-thirds of patients with multiple sclerosis and reduce delays in immunosuppressive treatment initiation.

MULTIPLE SCLEROSIS JOURNAL (2023)

Article Clinical Neurology

Association of Very Early Treatment Initiation With the Risk of Long-term Disability in Patients With a First Demyelinating Event

Alvaro Cobo-Calvo, Carmen Tur, Susana Otero-Romero, Pere Carbonell-Mirabent, Mariano Ruiz, Agustin Pappolla, Javier Villacieros Alvarez, Angela Vidal-Jordana, Georgina Arrambide, Joaquin Castillo, Ingrid Galan, Marta Rodriguez Barranco, Luciana Soledad Midaglia, Carlos Nos, Breogan Rodriguez Acevedo, Ana Zabalza de Torres, Neus Mongay, Jordi Rio, Manuel Comabella, Cristina Auger, Jaume Sastre-Garriga, Alex Rovira, Mar Tintore, Xavier Montalban

Summary: This study aimed to evaluate the impact of early treatment on the long-term disability risk of patients with a first demyelinating event, including MR scores. The results showed that early treatment can reduce disability risk and improve clinical outcomes.

NEUROLOGY (2023)

Article Clinical Neurology

Evolution of brain MRI lesions in paediatric myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and its relevance to disease course

Omar Abdel-mannan, Dimitrios Champsas, Carmen Tur, Vanessa Lee, Sharmila Manivannan, Haroon Usman, Alison Skippen, Ishita Desai, Manali Chitre, Rob Forsyth, Rachel Kneen, Dipak Ram, Sithara Ramdas, Thomas Rossor, Siobhan West, Sukhvir Wright, Jacqueline Palace, Evangeline Wassmer, Cheryl Hemingway, Ming J. Lim, Kshitij Mankad, Olga Ciccarelli, Yael Hacohen

Summary: Lesion dynamics differ significantly between MOGAD and MS, suggesting greater potential for repair in MOGAD. Early treatment with steroids and plasma exchange is associated with reduced likelihood of new lesions.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Review Radiology, Nuclear Medicine & Medical Imaging

Advanced Diffusion-Weighted MRI for Cancer Microstructure Assessment in Body Imaging, and Its Relationship With Histology

Ella Fokkinga, Juan A. Hernandez-Tamames, Andrada Ianus, Markus Nilsson, Chantal M. W. Tax, Raquel Perez-Lopez, Francesco Grussu

Summary: This article reviews the latest developments in diffusion-weighted magnetic resonance imaging (DW-MRI) in the field of oncology, analyzing its value compared to histology measurements. The reviewed techniques provide histologically meaningful indices of cancer microstructure and have sensitivity to microscopic pathological processes.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2023)

暂无数据